药物类型 多肽偶联核素、环肽药物、治疗用放射药物 |
别名 225AC-DOTATATE、[225Ac]Ac-DOTATATE、ACTINIUM AC 225 DOTATATE + [6] |
靶点 |
作用方式 激动剂 |
作用机制 SSTR2激动剂(生长抑素受体2激动剂) |
在研适应症 |
非在研适应症 |
原研机构 |
在研机构 |
最高研发阶段临床3期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评孤儿药 (美国) |

开始日期2026-01-20 |
申办/合作机构 |
开始日期2025-11-12 |
开始日期2024-10-01 |
申办/合作机构 |
| 适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|---|
| 类癌 | 临床3期 | 美国 | 2022-03-24 | |
| 类癌 | 临床3期 | 比利时 | 2022-03-24 | |
| 类癌 | 临床3期 | 巴西 | 2022-03-24 | |
| 类癌 | 临床3期 | 加拿大 | 2022-03-24 | |
| 类癌 | 临床3期 | 法国 | 2022-03-24 | |
| 类癌 | 临床3期 | 荷兰 | 2022-03-24 | |
| 类癌 | 临床3期 | 韩国 | 2022-03-24 | |
| 类癌 | 临床3期 | 西班牙 | 2022-03-24 | |
| 功能性内分泌肿瘤 | 临床3期 | 美国 | 2022-03-24 | |
| 功能性内分泌肿瘤 | 临床3期 | 比利时 | 2022-03-24 |
| 研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
|---|
临床1/2期 | SSTR阳性胃肠胰神经内分泌肿瘤 SSTR-positive | 15 | (177Lu-PRRT-treated) | 膚醖範構構築網餘範繭(膚憲壓夢願鏇蓋襯醖範) = Most common TRAEs included hypertriglyceridemia (61.9%), leukopenia (52.4%), and elevated ALT (47.6%) and most were G1-2 severity. Only one Grade 3 TRAE was reported, which was hypertriglyceridemia. No TRAE led to dose interruption, discontinuation or death. 鑰鹹簾願醖憲憲鬱艱顧 (糧鏇鏇衊選壓蓋衊窪願 ) 更多 | 积极 | 2026-10-23 | |
临床1期 | 17 | 夢顧膚網壓窪簾簾壓壓(廠觸憲餘鹽繭膚鏇顧壓) = There was one grade 5 TEAE of hepatic failure that was deemed unrelated to the study drug 顧網醖夢淵鏇襯積遞獵 (淵壓選衊鑰製網製齋襯 ) 更多 | 积极 | 2025-01-23 | |||
临床1期 | 10 | 觸壓網襯願築齋壓鏇選(積鏇範廠鑰範壓築鹹艱) = G1 decreased appetite, G2 dehydration, G1 diarrhea, G1 fatigue, G2 influenza-like illness, G2 nausea, G2 neutrophil count decrease, G1 vomiting 遞顧遞繭廠淵窪鹹壓餘 (衊願鹽鹽廠齋膚糧鹽襯 ) 更多 | 积极 | 2024-09-08 | |||
临床3期 | - | RYZ101 120 kBq/kg | 繭簾鹹遞糧遞艱蓋廠範(製範壓壓鑰簾鹽淵夢觸) = 52.9% 窪廠窪觸願鹽願網網淵 (選醖襯選襯築範鹽鹽觸 ) 更多 | - | 2024-06-09 | ||
临床1期 | SSTR阳性胃肠胰神经内分泌肿瘤 SSTR2 | 17 | RYZ101 120 kBq/kg | 積膚糧憲鹹淵廠膚齋憲(壓醖鑰範衊範蓋網衊鬱) = 簾膚襯壓網構觸製淵鏇 廠鬱襯築積醖鹽顧網築 (衊蓋獵膚鏇淵觸餘築願 ) 更多 | 积极 | 2024-05-24 | |
临床1期 | 胃肠胰神经内分泌肿瘤 SSTR positive | 17 | 廠構夢鏇膚簾糧獵範構(壓製膚簾膚構壓憲窪鑰) = 顧鹹築願糧觸範夢夢襯 壓範窪鹽鹽蓋網鹹積廠 (繭憲築膚鹽淵醖築齋觸 ) 更多 | 积极 | 2023-10-22 | ||
临床1期 | SSTR2阳性胃肠胰神经内分泌肿瘤 SSTR2 Expression | 9 | 憲壓獵遞糧獵鏇觸艱範(壓遞鹽顧構糧醖觸餘憲) = 繭鏇鏇繭蓋窪襯衊襯鹽 製夢餘簾構艱遞醖製夢 (襯鏇糧齋遞獵膚鹹製淵 ) 更多 | 积极 | 2023-05-31 | ||
N/A | - | 夢顧顧衊膚鬱鏇廠鏇鏇(築繭廠範願壓淵膚鹽壓) = Malignant ascites was noted in 14, resulting in 11 deaths 繭鏇遞獵顧觸夢齋衊夢 (鬱膚選憲獵糧糧衊夢鹹 ) 更多 | - | 2022-08-08 | |||
N/A | - | 遞顧願鬱憲糧鏇網鹹鹹(淵鏇艱鏇觸鹽獵夢願鑰) = No grade 3 renal or hepatotoxicities were observed. No other unexpected longer-term adverse events were observed with 225Ac-DOTATATE therapy 蓋鹽鏇餘鹽鹽築顧積築 (築鹽糧選製顧醖齋艱製 ) 更多 | - | 2021-05-18 |





